I’m not a fish eater. I never have been. Unless the seafood is lobster, shrimp, clams, or crab cakes…
Ed Tobias
People say to write what you know and Ed Tobias knows about MS. He's lived with the illness since 1980, when he was 32 years old. Ed's a retired, award-winning broadcast journalist and his column combines his four decades of MS experiences with news and comments about the latest in the MS community. In addition to writing his column, Ed is one of the patient moderators on the MS News Today Facebook, Twitter, and Instagram sites. He’s also the author of “The Multiple Sclerosis Toolbox: Hints and Tips for Living with M.S.” Ed and his wife split their time between the Washington, D.C. suburbs and Florida’s Gulf Coast, trying to follow the sun.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ed Tobias
After I wrote about pediatric MS earlier this month, a reader commented: “I think it would behoove your…
Biogen and AbbVie Voluntarily Withdraw Marketing Authorizations for MS Therapy Zinbryta You may have heard…
You know about credit cards that offer you cash back for the items you buy. How about getting…
MS Can Be a Kids’ Disease, Too
The age at which a person is diagnosed with MS is usually between 20 and 50, according to…
MS News that Caught My Eye Last Week: Epstein-Barr Virus, Gilenya, Naltrexone, Medical Marijuana
Epstein-Barr Virus Found in Brain Cells of Many MS Patients, Study Reports This study is yet…
The newest kids on the MS block, disease-modifying therapies (DMT) such as Genentech’s Ocrevus (ocrelizumab) and Sanofi Genzyme’s Lemtrada…
MS News that Caught My Eye Last Week: Mediterranean Diet, Medical Marijuana, Ocrevus, Myelin Repair
Pilot Study Is Testing Whether Mediterranean Diet Can Help MS Patients There’s been a good deal of…
My knee was jerking the other day. It wasn’t my MS, it was my knee-jerk reaction to the passage…
I know, I know. I write about health issues on the internet, so I shouldn’t be discouraging…
Stem Cell Treatment Benefits Three-fourths of MS Patients in Phase 1 Trial This is encouraging news for…
Several years ago, I tried to get my insurance company to approve a functional electronic stimulator (FES).
It’s nice when a negative experience can be turned into one that’s positive. I think that’s the result for…
#ACTRIMS2018 – Third Course of Lemtrada Improves Relapse, Disability in MS Patients, CARE-MS II Trial Shows The normal treatment…
One of the many disease-modifying therapies (DMTs) that I’ve been on over the many years of my treatment for…
A columnist reflects on a common MS experience: raising concerns that feel dismissed during medical care. This piece looks at patient advocacy when changing doctors is not easy, and how you can work toward better communication and care.
Researchers Identify Testosterone-triggered Molecule That Protects Men From MS This finding is an extension…
Have you been in this Catch-22? You had great medical insurance when you were working. But, you’re not working…
You may have heard that there’s a new secretary of Health and Human Services (HHS) in the United States.
Holland Approves Clinical Trial Plans for AXIM’s Cannabis-based Gum for MS Pain and Spasticity Because the state…
The TV was on as background noise the other day, but the words of the commercial cut right through…
I’m used to seeing insurance companies here in the United States make decisions about MS therapies, including refusing…
European Commission Approves Ocrevus to Treat RRMS, PPMS Throughout EU This is a biggie. It’s been nearly…
I’m sitting in Florida and the start of spring training is only about six weeks from now, so…
A Tough Year to Fight the Flu
I’m fighting a cold. I’m coughing and I’m congested. I’m hoping it’s not the flu. This is not…
MS News that Caught My Eye Last Week: Rituxan, Medical Marijuana for Canadians, Extavia, Atira Trial
Newly Diagnosed MS Patients Stay Longer on Rituxan Than Other Therapies, Study Finds This is a study…
The Food and Drug Administration (FDA) issued a safety alert about gadolinium, the dye that’s injected when…
Diagnosing MS Faster and Better
As we all know, MS is difficult to diagnose. Put another way, it’s easy to misdiagnose. There’s no…
FDA Warns of Risks Linked to Gadolinium-based Contrast Agents Used in MRI Scans I had a brain…
Happy new year to all. The start of the new year seems like a good time to assess…